Skip to main content

Table 2 Numbers of patients positive and negative for lipoarabinomannan (LAM) in the CSF in the definite, probable and non-tuberculous meningitis (TBM) groups

From: Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting

Diagnosis (Number)

LAM +ve (%)

LAM -ve

(%)

Definite TBM (14)

9 (64)

5 (36)

Probable TBM (23)

6 (26)

17 (74)

Non-TBM (13)

5 (38.5)

8 (61.5)